Effects of a Copper-Deficient Diet on the Biochemistry, Neural Morphology and Behavior of Aged Mice

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Bolognin, Silvia ^a   Pasqualetto, Federica ^a   Mucignat Caretta, Carla ^a   Scancar, Janez ^b   Milacic, Radmila ^b   Zambenedetti, Pamela ^c   Cozzi, Bruno ^a   Zatta, Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b JO EF STEFAN INSTITUTE   (Slovenia)

^c Department of Pathology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; CALCIUM; COPPER; IRON; METALLOTHIONEIN I; METALLOTHIONEIN II; TYROSINE 3 MONOOXYGENASE; ZINC;

AGED; AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN TISSUE; CONTROLLED STUDY; COPPER DEFICIENCY; EXPERIMENTAL TEST; HABITUATION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROANATOMY; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; POLE TEST; PREDATION; PROTEIN ANALYSIS; TISSUE LEVEL;

AGING; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; COPPER; DIET; MALE; METALLOTHIONEIN; METALS; MICE; MICE, INBRED STRAINS; PREDATORY BEHAVIOR; TISSUE DISTRIBUTION; TYROSINE 3-MONOOXYGENASE;

EID: 84867392661     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047063     Document Type: Article

References (55)

1. Gaeta A, Hider RC, (2005) The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br J Pharmacol 146: 1041-1059.
2. White AR, Barnham KJ, Bush AI, (2006) Metal homeostasis in Alzheimer's disease. Expert Rev Neurother 6: 711-722.
3. Drago D, Bolognin S, Zatta P, (2008) Role of metal ions in the abeta oligomerization in Alzheimer's disease and in other neurological disorders. Curr Alzheimer Res 5: 500-507.
4. Bonda DJ, Lee HG, Blair JA, Zhu X, Perry G, et al. (2011) Role of metal dyshomeostasis in Alzheimer's disease. Metallomics 3: 267-270.
5. Zatta P, Frank A, (2007) Copper deficiency and neurological disorders in man and animals. Brain Res Rev 54: 19-33.
6. Cuajungco MP, Faget KY, Huang X, Tanzi RE, Bush AI, (2000) Metal chelation as a potential therapy for Alzheimer's disease. Ann N Y Acad Sci 920: 292-304.
7. Opazo C, Huang X, Cherny RA, Moir RD, Roher AE, et al. (2002) Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). J Biol Chem 277: 40302-40308.
8. Deibel MA, Ehmann WD, Markesbery WR, (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci 143: 137-142.
9. Loeffler DA, DeMaggio AJ, Juneau PL, Brickman CM, Mashour GA, et al. (1994) Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease. Alzheimer Dis Assoc Disord 8: 190-197.
10. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR, (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158: 47-52.
11. Crouch PJ, Barnham KJ, Bush AI, White AR, (2006) Therapeutic treatments for Alzheimer's disease based on metal bioavailability. Drug News Perspect 19: 469-474.
12. Borchardt T, Camakaris J, Cappai R, Masters CL, Beyreuther K, et al. (1999) Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion. Biochem J 344 Pt 2: 461-467.
13. Phinney AL, Drisaldi B, Schmidt SD, Lugowski S, Coronado V, et al. (2003) In vivo reduction of amyloid-beta by a mutant copper transporter. Proc Natl Acad Sci U S A 100: 14193-14198.
14. Bayer TA, Schafer S, Simons A, Kemmling A, Kamer T, et al. (2003) Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proc Natl Acad Sci U S A 100: 14187-14192.
15. Crouch PJ, Hung LW, Adlard PA, Cortes M, Lal V, et al. (2009) Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation. Proc Natl Acad Sci U S A 106: 381-386.
16. Kessler H, Pajonk FG, Bach D, Schneider-Axmann T, Falkai P, et al. (2008) Effect of copper intake on CSF parameters in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial. J Neural Transm 115: 1651-1659.
17. Quinn JF, Crane S, Harris C, Wadsworth TL, (2009) Copper in Alzheimer's disease: too much or too little? Expert Rev Neurother 9: 631-637.
18. Sparks DL, Schreurs BG, (2003) Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc Natl Acad Sci U S A 100: 11065-11069.
19. Morris MC, Evans DA, Tangney CC, Bienias JL, Schneider JA, et al. (2006) Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Arch Neurol 63: 1085-1088.
20. Kitazawa M, Cheng D, Laferla FM, (2009) Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD. J Neurochem 108: 1550-1560.
21. Bolognin S, Drago D, Messori L, Zatta P, (2009) Chelation therapy for neurodegenerative diseases. Med Res Rev 29: 547-570.
22. Ames BN, (2006) Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc Natl Acad Sci U S A 103: 17589-17594.
23. Murko S, Milacic R, Scancar J, (2007) Speciation of Al in human serum by convective-interaction media fast-monolithic chromatography with inductively coupled plasma mass spectrometric detection. J Inorg Biochem 101: 1234-1241.
24. Scheuhammer AM, Cherian MG, (1986) Quantification of metallothioneins by a silver-saturation method. Toxicol Appl Pharmacol 82: 417-425.
25. Scheuhammer AM, Cherian MG, (1991) Quantification of metallothionein by silver saturation. Methods Enzymol 205: 78-83.
26. Mucignat-Caretta C, Bondi M, Caretta A, (2004) Animal models of depression: olfactory lesions affect amygdala, subventricular zone, and aggression. Neurobiol Dis 16: 386-395.
27. Sedelis M, Schwarting RK, Huston JP, (2001) Behavioral phenotyping of the MPTP mouse model of Parkinson's disease. Behav Brain Res 125: 109-125.
28. Kurosaki R, Muramatsu Y, Kato H, Araki T, (2004) Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease. Pharmacol Biochem Behav 78: 143-153.
29. Pankevich DE, Baum MJ, Cherry JA, (2004) Olfactory sex discrimination persists, whereas the preference for urinary odorants from estrous females disappears in male mice after vomeronasal organ removal. J Neurosci 24: 9451-9457.
30. Penland JG, Prohaska JR, (2004) Abnormal motor function persists following recovery from perinatal copper deficiency in rats. J Nutr 134: 1984-1988.
31. Gybina AA, Tkac I, Prohaska JR, (2009) Copper deficiency alters the neurochemical profile of developing rat brain. Nutr Neurosci 12: 114-122.
32. Reeves PG, DeMars LC, (2004) Copper deficiency reduces iron absorption and biological half-life in male rats. J Nutr 134: 1953-1957.
33. Monnot AD, Zheng G, Zheng W, (2012) Mechanism of copper transport at the blood-cerebrospinal fluid barrier: influence of iron deficiency in an in vitro model. Exp Biol Med (Maywood) 237: 327-333.
34. Yoshihara D, Fujiwara N, Kato S, Sakiyama H, Eguchi H, et al. (2012) Alterations in renal iron metabolism caused by a copper/zinc-superoxide dismutase deficiency. Free Radic Res 46: 750-757.
35. Roeser HP, Lee GR, Nacht S, Cartwright GE, (1970) The role of ceruloplasmin in iron metabolism. J Clin Invest 49: 2408-2417.
36. Chen H, Huang G, Su T, Gao H, Attieh ZK, et al. (2006) Decreased hephaestin activity in the intestine of copper-deficient mice causes systemic iron deficiency. J Nutr 136: 1236-1241.
37. Vulpe CD, Kuo YM, Murphy TL, Cowley L, Askwith C, et al. (1999) Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 21: 195-199.
38. Harris ZL, Klomp LW, Gitlin JD, (1998) Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr 67: 972S-977S.
39. Reeves PG, Ralston NV, Idso JP, Lukaski HC, (2004) Contrasting and cooperative effects of copper and iron deficiencies in male rats fed different concentrations of manganese and different sources of sulfur amino acids in an AIN-93G-based diet. J Nutr 134: 416-425.
40. Pyatskowit JW, Prohaska JR, (2008) Copper deficient rats and mice both develop anemia but only rats have lower plasma and brain iron levels. Comp Biochem Physiol C Toxicol Pharmacol 147: 316-323.
41. Miyoshi I, Saito T, Iwahara Y, (2004) Copper deficiency anaemia. Br J Haematol 125: 106.
42. Pyatskowit JW, Prohaska JR, (2008) Iron injection restores brain iron and hemoglobin deficits in perinatal copper-deficient rats. J Nutr 138: 1880-1886.
43. Prohaska JR, Bailey WR, (1993) Persistent regional changes in brain copper, cuproenzymes and catecholamines following perinatal copper deficiency in mice. J Nutr 123: 1226-1234.
44. Johnson WT, Dufault SN, (1993) Intracellular calcium mobilization in rat platelets is adversely affected by copper deficiency. Biochim Biophys Acta 1175: 263-268.
45. Wildman RE, Hopkins R, Failla ML, Medeiros DM, (1995) Marginal copper-restricted diets produce altered cardiac ultrastructure in the rat. Proc Soc Exp Biol Med 210: 43-49.
46. Johnson WT, Johnson LK, (2009) Copper deficiency inhibits Ca2+-induced swelling in rat cardiac mitochondria. J Nutr Biochem 20: 248-253.
47. Chao JC, Medeiros DM, Davidson J, Shiry L, (1994) Low levels of ATP synthase and cytochrome c oxidase subunit peptide from hearts of copper-deficient rats are not altered by the administration of dimethyl sulfoxide. J Nutr 124: 789-803.
48. Medeiros DM, Davidson J, Jenkins JE, (1993) A unified perspective on copper deficiency and cardiomyopathy. Proc Soc Exp Biol Med 203: 262-273.
49. Kang YJ, (2006) Metallothionein redox cycle and function. Exp Biol Med (Maywood) 231: 1459-1467.
50. Maret W, (1994) Oxidative metal release from metallothionein via zinc-thiol/disulfide interchange. Proc Natl Acad Sci U S A 91: 237-241.
51. Maret W, (1995) Metallothionein/disulfide interactions, oxidative stress, and the mobilization of cellular zinc. Neurochem Int 27: 111-117.
52. Kang YJ, Jiang Y, Saari JT, (2007) Changes in copper and zinc status and response to dietary copper deficiency in metallothionein-overexpressing transgenic mouse heart. J Nutr Biochem 18: 714-718.
53. Yang HY, Wang YM, Peng SQ, (2010) Metallothionein-I/II null cardiomyocytes are sensitive to Fusarium mycotoxin butenolide-induced cytotoxicity and oxidative DNA damage. Toxicon 55: 1291-1296.
54. Koumura A, Hamanaka J, Shimazawa M, Honda A, Tsuruma K, et al. (2009) Metallothionein-III knockout mice aggravates the neuronal damage after transient focal cerebral ischemia. Brain Res 1292: 148-154.
55. Maret W, (2008) Metallothionein redox biology in the cytoprotective and cytotoxic functions of zinc. Exp Gerontol 43: 363-369.